US and Canadian markets settled this week on a positive note, Two stocks to consider – SASK, IPSC

Company Overview: ATHA Energy Corp. (TSXV: SASK) is a Canadian mineral exploration company focused on the acquisition, exploration, and development of uranium assets. The Company’s strategic objective is to advance its uranium projects to support the growing demand for clean, sustainable energy solutions in the transition to a low-carbon future. Century Therapeutics Inc. (NASDAQ: IPSC) is a biotechnology company focused on developing transformative allogeneic cell therapies for the treatment of both solid tumors and hematological malignancies. This Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks. 

Global Markets Wrap-Up

As of July 24, 2025, major U.S. equity indices recorded positive week-to-date (WTD) performances, supported by broad-based sector strength. The S&P 500 edged up 0.85% to close at 6,363.35, while the NASDAQ Composite advanced 1.51% to 21,057.96, driven by sustained momentum in the technology sector. The Russell 2000, which tracks small-cap stocks, also posted gains, rising 0.54% to finish the week at 2,252.13.

In Canada, the S&P/TSX Venture Composite Index advanced 0.65% week-to-date (WTD) to close at 802.93, extending its broader uptrend. Thursday’s session saw notable strength across the technology, financials, real estate, and energy sectors, providing near-term support and reinforcing pockets of bullish momentum. However, these gains were partially offset by continued weakness in industrials, consumer cyclicals, consumer non-cyclicals, basic materials, and healthcare. This sectoral divergence highlights ongoing investor caution, which is tempering the broader rally and signalling a selective risk-on approach despite the index’s recent resilience.

Considering the US and Canadian markets’ performance over the week, following the significant global macros and data front, two stocks that fit the criteria on the technical framework: ATHA Energy Corp. (TSXV: SASK) and Century Therapeutics Inc. (NASDAQ: IPSC). The recommendations on these stocks are based on the generic insights, entry price, target prices, and stop-loss for the next 2-6 weeks:

ATHA Energy Corp. (TSXV: SASK)

Noted below are the key price indicators for the stock:

Price Action Analysis (On the Daily Chart)

On the daily chart, SASK continues to trade above a key falling support trendline, indicating sustained price strength and supporting the potential for further upside in the near term. The stock is steadily approaching a critical resistance level near CAD 0.760, which could be tested within the next 2 to 6 weeks if current bullish momentum persists. A decisive breakout above this zone would likely act as a strong bullish catalyst, drawing renewed buying interest and potentially setting the stage for an extended rally.

Technical Analysis (On the Daily Chart)

The 14-period Relative Strength Index (RSI) is currently at 64.17, indicating a potential shift toward bullish momentum. This emerging strength is further reinforced by robust weekly trading volumes, which reflect sustained buying interest and increasing investor confidence. Additionally, the stock continues to trade above its 21-period Simple Moving Average (SMA) a key trend-following indicator which may serve as near-term support, helping to maintain the current upward trajectory.

General Recommendation:

As per the above-mentioned price action and technical indicators analysis, ATHA Energy Corp. is looking technically well-placed on the chart, and a ‘Speculative Buy’ recommendation has been given on the stock. The summary of recommendations is as follows:

Century Therapeutics Inc. (NASDAQ: IPSC)

Noted below are the key price indicators for the stock:

Price Action Analysis (On the Daily Chart)

On the daily chart, IPSC continues to trade above a horizontal trendline support, signalling sustained price stability and supporting the potential for continued upside momentum in the near term.The next key resistance is near USD 0.770, which could be tested within 2 to 6 weeks if the current bullish structure holds. A decisive breakout above this level would likely serve as a bullish catalyst, attracting increased buying interest and potentially paving the way for a more sustained uptrend.

Technical Analysis (On the Daily Chart)

On the daily chart, the 14-period Relative Strength Index (RSI) is currently at 65.35, reflecting bullish momentum and signalling room for further upside. Weekly trading volumes remain consistent, highlighting a steady base of buying interest that supports the potential for continued gains. Additionally, the stock is trading above its 21-period Simple Moving Average (SMA), which now acts as a dynamic support level, reinforcing the strength of the current uptrend and improving the overall technical outlook.

General Recommendation:

As per the above-mentioned price action and technical indicators analysis, Century Therapeutics Inc. is looking technically well-placed on the chart, and a ‘Speculative Buy’ recommendation has been given on the stock. The summary of recommendations is as follows:

Investment decisions should be made depending on an individual's appetite for upside potential, risks, and any previous holdings. This recommendation is purely based on technical analysis, and fundamental analysis has not been considered in this report.

Upcoming Major Global Economic Events 

Market events occur daily depending on the data's frequency and generally include updates on CPI, PPI, Core Retail Sales, Unemployment Data, etc. The upcoming week's major global economic events that could impact the S&P/TSX Venture Composite Index and listed stocks' prices are noted below.

Related Risks: This report may be looked at from a high-risk perspective and recommendation is provided for a short duration. Recommendations provided in this report are solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc.

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing. 

Kalkine reports are prepared based on the stock prices captured from either REFINITIV or Trading View. Typically, REFINITIV or Trading View may reflect stock prices with a delay which could be a lag of 25-30 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’ 

Note 1: Individuals can consider exiting from the stock if the Target Price or Stop loss mentioned as per the technical analysis has been achieved and subject to the factors discussed above. 

Note 2: How to Read the Charts?

The Green color line reflects the 21-period moving average, while the red color line indicates the 50-period moving average. SMA helps to identify existing price trend. If the prices are trading above the 21-period and 50-period moving average, then it shows prices are currently trading in a bullish trend.

The Black color line in the chart's lower segment reflects the Relative Strength Index (14-Period), which indicates price momentum and signals momentum in trend. A reading of 70 or above suggests overbought status, while a reading of 30 or below suggests an oversold status.

The Blue color bars in the chart's lower segment show the volume of the stock. The volume is the number of shares that changed hands during a given day. Stocks with high volumes are more liquid than stocks with lesser volume. Liquidity in stocks helps in easier and faster execution of the order.

The Orange color lines are the trend lines drawn by connecting two or more price points and used for trend identification purposes. The trend line also acts as a line of support and resistance.

Technical Indicators Defined: - 

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock. 

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock. 

Stop-loss: In general, it is a level to protect further losses in case of unfavorable movement in the stock prices.

Risk Reward Ratio: The risk reward ratio is the difference between an entry point to a stop loss and profit level and the report is based on ~80% Stop Loss of the Target 1 from the entry point.

A trailing stop-loss is a modification of stop-loss in case of favorable movement in the price to protect the gains. Individual can Trail the Stop-Loss as per the levels if the stock price achieves more than 50% of the Target 1. Individual should consider exiting from the position as per the Trailing Stop-Loss level if the price starts moving downwards after achieving more than 50% of the Target 1.

The reference date for all price data, currency, technical indicators, support, and resistance levels is July 24, 2025. The reference data in this report has been partly sourced from REFINITIV.

Abbreviations

CMP: Current Market Price

SMA: Simple Moving Average

CAD: Canadian Dollar

RSI: Relative Strength Index

USD: United States dollar 

Note: Trading decisions require a thorough analysis by individuals. Technical reports in general chart out metrics that may be assessed by individuals before any stock evaluation. The above are illustrative analytical factors used for evaluating the stocks; other parameters can be looked at along with additional risks per se. Past performance is neither an indicator nor a guarantee of future performance.